20123 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials; Organic compounds, e.g. fats Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE
#2Sugar Free Soft Chew Tablets
#3POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
#4PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDE
#5CONSUMER PRODUCT TABLET USING DIRECT COMPRESSION
#6CONTROLLED RELEASE COMPOSITION AND METHOD
#7Membrane-forming composition, membrane-like composition, and use of same
#8DOSAGE FORM WITH DRUG RELEASE AT PH 3 TO 6 USING DOUBLE COATING SYSTEM WITH AT LEAST ONE RELEASE ACCELERATION AGENT
#9DOSING REGIMENS FOR TREATING PAIN
#10Obicetrapib and SGLT2 Inhibitor Combination
#11PHARMACEUTICAL FORMULATION
#12FORMULATIONS OF MAZINDOL
#13SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS
#14SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS
#15FLAMMULINA VELUTIPES PROTEOGLYCAN (FPG) AND DUAL-WAVELENGTH SCREENING METHOD AND USE THEREOF
#16TETRAZOLE DERIVATIVES
#17Compositions comprising a cannabinoid and uses thereof
#18IMPROVED SUGAR COATING PROCESS COMPRISING A HYDROLYZED AND FUNCTIONALIZED STARCH
#19CHEMICAL COMPOSITION FOR ENTERIC DRUG DELIVERY
#20DRUG DELIVERY SYSTEM
#21SLEEP-REGULATING TABLET ALLOWING RELEASE BY STAGES AND PREPARATION METHOD THEREOF
#22POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY
#23SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NEUROTROPHIC AND NEUROPROTECTIVE COMPOSITIONS
#24PHARMACEUTICAL FORMULATIONS
#25ENTERIC-COATED PELLET, METHOD FOR PREPARING SAME AND FORMULATION COMPRISING SAME
#26ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A METHYL HYDROGEN FUMARATE PRODRUG
#27TETRAZOLE DERIVATIVES
#28ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION
#29SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS
#30FILM-COATED TABLET
#31OSMOTIC DRUG DELIVERY SYSTEM
#32TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#33Pharmaceutical Compositions Containing Enterokine Releasing Substances In Multiple Dosage Forms In Combination With Gelling Agents
#34PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#35FORMULATIONS OF MAZINDOL
#36TETRAZOLE DERIVATIVES
#37OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES
#38CONTROLLED RELEASE COMPOSITION AND METHOD
#39Dosage form for use in treating or preventing of a disease
#40NOVEL FILM COATING COMPOSITION
#41PHARMACEUTICAL COMPOSITION OF DAROLUTAMIDE
#42PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF
#43COMPOSITIONS OF FILM COATINGS FOR TABLETS WITH INCREASED GLOSS, METHOD FOR PRODUCTION THEREOF AND APPLICATION OF SAME
#44COMPOSITIONS OF PROTEINS WITH DIPEPTIDES AS STABILISING AGENTS
#45PHARMACEUTICAL COMPOSITION COMPRISING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HAVING DOUBLE-RELEASE PROFILE
#46Tablet dosage formulations of oleyl phosphocholine
#47Sustained release solid dosage forms for modulating the colonic microbiome
#48Pharmaceutical compositions comprising coated API
#49SUGAR-COATED SOLID FORMS HAVING IMPROVED STABILITY
#50SOLID ORAL DOSAGE FORM HAVING EXCELLENT DISSOLUTION PROPERTIES
#51DRUG DELIVERY SYSTEM
#52METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES
#53TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#54ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF
#55COATING COMPOSITION, ORAL SOLID PREPARATION, AND METHOD FOR PRODUCING THE ORAL SOLID PREPARATION
#56ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#57FORMULATIONS OF (+)-2-[1-(3-ETHOXY-4- METHOXY-PHENYL)-2-METHANESULFONYL- ETHYL]-4-ACETYLAMINOISOINDOLINE-1,3- DIONE
#58Ibudilast oral formulations and methods of using same
#59Linear glycosidase inhibitors
#60Avoiding gag reflex to enable swallowing pills
#61Sustained release solid dosage forms for modulating the colonic microbiome
#62Dextromethorphan extended release pharmaceutical composition
#63Avoiding gag reflex to enable swallowing pills
#64Film-coated tablet having high chemical stability of active ingredient
#65OSMOTIC DRUG DELIVERY SYSTEM
#66Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#67SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS
#68OSMOTIC DRUG DELIVERY SYSTEM
#69Film coating composition and methods of making and using the same
#70ORALLY DISINTEGRATING TABLET HAVING INNER CORE
#71TIOPRONIN ORAL COMPOSITION
#72SUBSTITUTED QUINOXALINE DERIVATIVES AS INHIBITORS OF PFKFB
#73Orally disintegrating tablet coated with film
#74ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#75FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEREOF
#76Method of long-term preservation of chemical and biological species using sugar glasses
#77Particle composition for easy-to-use solid preparation and easy-to-use solid preparation including said particle composition
#78Gut health compositions
#79Compositions and methods for controlling carbohydrate and fat metabolism
#80Pharmaceutical dosage forms
#81Film-forming compositions for the film-coating of solid forms
#82CONTROLLED RELEASE COMPOSITION AND METHOD
#83METHOD FOR ACCELERATING THE SUGAR-COATING FORMATION OF SUGAR ALCOHOL COATING WITH CALCIUM LACTATE
#84Pharmaceutical compositions of linagliptin and process for preparation thereof
#85Rice bran sterol sugar-coated tablet
#86Film-forming compositions based on starchy material and articles obtained thereof
#87MTAB-TA-Coated gold nanorods and method of fabrication
#88Production method for easy-to-take solid preparation, and easy-to-take solid preparation
#89Pharmaceutical bead formulations comprising dimethyl fumarate
#90Production method for easy-to-take solid preparation (nucleated tablet), and easy-to-take solid preparation
#91Oral dosage form containing a fast release exterior coating
#92Drug delivery system
#93NOVEL FILM COATING COMPOSITION
#94Formulations of histone deacetylase inhibitor and uses thereof
#95Film coating composition and methods of making and using the same
#96Pharmaceutical dosage forms
#97NOVEL PULSATILE DRUG DELIVERY SYSTEM
#98PHARMACEUTICAL COMPOSITION CONTAINING PREGABALIN WITH IMPROVED STABILITY AND METHOD FOR PREPARING SAME
#99PHARMACEUTICAL SYSTEM FOR ORAL DELIVERY OF SENSITIVE THERAPEUTIC SUBSTANCES
#100Easily dosable solid preparation
#101MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
#102Coating agent for solid preparation, and film and coated solid preparation formed therewith
#103Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
#104Compositions and methods for controlling carbohydrate and fat metabolism
#105Controlled-release solid preparation with partial coating
#106Heteroaryl compounds as BTK inhibitors and uses thereof
#107Osmotic drug delivery system
#108CONTROLLED-RELEASE DRUG FORMULATION
#109Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#110Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism
#111FILM-FORMING COMPOSTIONS FOR THE FILM-COATING OF SOLID FORMS
#112COMPOSITION FOR ORAL ADMINISTRATION FOR BINDING ALDEHYDES IN THE GASTROINTESTINAL TRACT
#113Pharmaceutical products
#114Compositions containing cyclic peptides and methods of use
#115CONTROLLED RELEASE COMPOSITION AND METHOD
#116Stable pharmaceutical compositions of saxagliptin or salts thereof
#117Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
#118Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
#119EASILY ADMINISTRABLE SOLID PREPARATION
#120Drug delivery system
#121ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#122Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#123PHARMACEUTICAL COMPOSITIONS OF N-METHYL-2-[3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL]-BENZAMIDE
#124Pharmaceutical Formulations Including An Amine Compound
#125Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#126Formulations of histone deacetylase inhibitor and uses therof
#127Oral Dosage Forms Having a High Loading of a Methyl Hydrogen Fumarate Prodrug
#128METHOD FOR PRODUCING GARDENIA BLUE PIGMENT
#129Methods of applying coating materials for solid medicines
#130Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
#131Oral antimicrobial pharmaceutical compositions
#132ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#133Oral antimicrobial pharmaceutical compositions
#134Sugar-coated preparation and production method for the same
#135Pyrimidinyl pyridazinone derivatives
#136Oral antimicrobial pharmaceutical compositions
#137Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate
#138Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
#139Easily administrable solid preparation
#140Therapeutic or prophylactic agent for dyskinesia
#141FORMULATIONS
#142Formulations of histone deacetylase inhibitor and uses thereof
#143ORALLY DISINTEGRATING TABLET HAVING INNER CORE
#144Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate
#145ERYTHRITOL-BASED HARD COATINGS
#146Film coating composition and methods of making and using the same
#147Coating composition and use thereof
#148Pyridazinone derivatives
#149Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting
#150Coating material for solid medicine and solid medicine formed with same
#151CHRONOTHERAPEUTIC DOSAGE FORMS AND METHODS OF TREATMENT USING CHRONOTHERAPY
#152WATER INSOLUBLE POLYMER: STARCH-BASED FILM COATINGS FOR COLON TARGETING
#153HYDROPHILIC AMINO ACID-CONTAINING PREPARATION HAVING IMPROVED TASTE
#154SUGAR COATINGS AND METHODS THEREFOR
#155OXYGEN BARRIER FILM COATINGS FOR PHARMACEUTICAL DOSAGE FORMS
#156COATING APPARATUS
#157PHARMACEUTICAL FORMULATIONS FOR THE ORAL ADMINISTRATION OF PPI
#158STABILIZED PICOPLATIN ORAL DOSAGE FORM
#159Compositions Containing Cyclic Peptides And Methods Of Use
#160Pyridazinone derivatives
#161Pyrimidinyl pyridazinone derivatives
#162STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM
#163Stabilized solid preparation
#164Dosage form time-lagged of drugs for the therapy of insomnia
#165FORMULATIONS CONTAINING PANTOPRAZOLE FREE ACID AND ITS SALTS
#166Method of manufacturing modified release dosage forms
#167METHOD OF DIP-COATING DOSAGE FORMS
#168SIROLIMUS HAVING SPECIFIC PARTICLE SIZE AND PHARMACEUTICAL COMPOSITIONS THEREOF
#169Formulations
#170Sugar-coated preparation
#171Polymer Composition And Dosage Forms Comprising The Same
#172Buffered coated nicotine containing products
#173ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#174Gastroretentive formulations and manufacturing process thereof
#175Sugar-coated agent
#176PHARMACEUTICAL COMPOSITION OF ZOLPIDEM
#177SUGAR COATINGS AND METHODS THEREFOR
#178SOLID ORAL DOSAGE VITAMIN AND MINERAL COMPOSITIONS
#179Method for dip coating dosage forms
#180Osmotic drug delivery system
#181Oral antimicrobial pharmaceutical compositions
#182Stable pharmaceutical formulations of montelukast sodium
#183Stable pharmaceutical formulations of montelukast sodium
#184Compression-coated tablets and manufacture thereof
#185Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
#186SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS
#187Ambroxol for the treatment of chronic pain
#188Compression coated tablets
#189Coating composition
#190Pharmaceutical tablets containing tibolone and a coating
#191Coating of tablet cores
#192Solid dosage form for acid-labile active ingredient
#193Chronotherapeutic dosage forms and methods of treatment using chronotherapy
#194Benzimidazole derivatives
#195Sugar coatings and methods therefor
#196Modified release dosage forms
#197Crystal forms of azithromycin
#198Crystal forms of azithromycin
#199Crystal forms of azithromycin
#200Powdery product comprising crystalline β-maltose monohydrate, its preparation, and uses
#201Sugar-free hard coatings prepared from liquid maltitol comprising DPfraction
#202Press-coated molded article undergoing quick disintegration
#203Crystal forms of azithromycin
#204Pharmaceutical formulations
#205Atomoxetine formulations
#206Systems, methods and apparatuses for manufacturing dosage forms
#207Carboxamide derivatives
#208Systems, methods and apparatuses for manufacturing dosage forms
#209Method and apparatus for transferring substrates
#210Crystal forms of azithromycin
#211Tablet with aqueous-based sustained release coating
#212Formulations
#213Composite dosage forms
#214Confectionery products for delivery of pharmaceutically active agents to the throat
#215Pharmaceutical composition of darolutamide
#216Solid oral formulations having an iron sugar overcoat
#217Pill-enveloping material to aid in swallowing pills